Mr. Pierre Laurin reports

CHITOGENX ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Philippe Deschamps, chief executive officer, has decided to step down as chief executive officer of Chitogenx Inc. for personal reasons and has resigned from the board of directors, effective Feb. 28, 2024. Pierre Laurin, who currently serves as chairman of the board of directors, will act as interim CEO while the board of directors reviews potential alternatives to fill the position permanently.

The board of directors of the company thanks Mr. Deschamps for his efforts and commitment over his tenure, and wishes him the best in his future endeavours. Mr. Deschamps intends to support the company during this period of transition.

About Chitogenx Inc.

Chitogenx is a clinical-stage regenerative medicine company dedicated to the development of novel therapeutic tissue repair technologies to improve tissue healing. The company is committed to the clinical development of its proprietary Chitosan-based biopolymer technology platform, a proprietary mucoadhesive scaffold specifically designed to be combined with therapeutics to improve tissue repair.

We seek Safe Harbor.